Status:
COMPLETED
Lower Protein Intake and Long-term Risk of Obesity and Cardiovascular Disease
Lead Sponsor:
Société des Produits Nestlé (SPN)
Collaborating Sponsors:
University College, London
Conditions:
Infant Formula
Growth
Eligibility:
All Genders
13-15 years
Phase:
NA
Brief Summary
The primary objective of this study is to investigate if consumption of lower protein formula can slow the rate of weight gain of formula-fed infants between 3 and 12 months of age. Secondary objectiv...
Detailed Description
Obesity and its cardiovascular consequences are the most important causes of morbidity and mortality worldwide. Breastfed infants have been shown to have less cardiovascular risk factors in adulthood,...
Eligibility Criteria
Inclusion
- Healthy term infant
- Infant is aged 14 weeks (+/- 1 week)
- Infant is exclusively formula feeding or predominantly breast-feeding at age 14 weeks
Exclusion
- Any adverse maternal, fetal or infant medical history that may have effects on growth and/or development
- Infant born with congenital disease or malformation affecting growth and/or development
- Food allergy to any trial products (e.g. milk, soy)
Key Trial Info
Start Date :
August 7 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
October 13 2022
Estimated Enrollment :
249 Patients enrolled
Trial Details
Trial ID
NCT03456934
Start Date
August 7 2017
End Date
October 13 2022
Last Update
March 17 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
UCL Institute of Child Health
London, United Kingdom, WC1N 1EH